|
DE69914932T2
(de)
*
|
1998-10-20 |
2004-12-09 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw. |
Verwendung eines zytokine-produzierenden lactococcus stammes zur behandlung von kolitis
|
|
AUPQ291499A0
(en)
*
|
1999-09-17 |
1999-10-07 |
Women's And Children's Hospital Adelaide |
Novel nitro and sulphur containing compounds
|
|
NO328803B1
(no)
*
|
2000-03-03 |
2010-05-18 |
Thia Medica |
Nye fettsyreanaloger
|
|
CN100553636C
(zh)
|
2000-08-04 |
2009-10-28 |
Dmi生物科学公司 |
二酮基哌嗪和包含它们的组合物的使用方法
|
|
NO20006008L
(no)
*
|
2000-11-28 |
2002-05-29 |
Thia Medica As |
Fettsyreanaloger for behandling av inflammatoriske og autoimmune sykdommer
|
|
US7780961B2
(en)
*
|
2001-05-03 |
2010-08-24 |
Actogenix N.V. |
Self-containing Lactococcus strain
|
|
WO2004030522A2
(en)
*
|
2002-10-02 |
2004-04-15 |
Dmi Biosciences, Inc. |
Diagnosis and monitoring of diseases
|
|
AU2003298291A1
(en)
*
|
2002-11-15 |
2004-06-15 |
Universiteit Gent |
Self-containing lactobacillus strain
|
|
GB0311081D0
(en)
*
|
2003-05-14 |
2003-06-18 |
Btg Internat Limted |
Treatment of neurodegenerative conditions
|
|
EP2517718B1
(en)
|
2003-05-15 |
2016-03-02 |
Ampio Pharmaceuticals, Inc. |
Treatment of T-cell mediated diseases
|
|
FI20060154A7
(fi)
|
2003-08-18 |
2006-05-11 |
Btg Int Ltd |
Neurogeneratiivisten tilojen hoito
|
|
DE10351111A1
(de)
*
|
2003-11-03 |
2005-06-16 |
Langlotz, Rainer |
Arzneimittel und Verfahren zu ihrer Herstellung
|
|
US20090215895A1
(en)
*
|
2004-01-30 |
2009-08-27 |
Peplin Biolipids Pty Ltd |
Therapeutic and carrier molecules
|
|
US7544714B2
(en)
*
|
2004-07-16 |
2009-06-09 |
University Of Massachusetts |
Lipid-amino acid conjugates and methods of use
|
|
GB0425932D0
(en)
*
|
2004-11-25 |
2004-12-29 |
Btg Int Ltd |
Structured phospholipids
|
|
GB0504333D0
(en)
*
|
2005-03-02 |
2005-04-06 |
Btg Int Ltd |
Treatment of cytokine dysregulation
|
|
GB0504362D0
(en)
*
|
2005-03-02 |
2005-04-06 |
Btg Int Ltd |
Cytokine modulators
|
|
US20060246115A1
(en)
*
|
2005-03-04 |
2006-11-02 |
Ricardo Rueda |
Nutritional products for ameliorating symptoms of rheumatoid arthritis
|
|
ES2405552T3
(es)
|
2005-11-29 |
2013-05-31 |
Actogenix N.V. |
Inducción de tolerancia mucosa a antiantígenos de células beta de islotes pancreáticos
|
|
WO2008090223A2
(en)
|
2007-01-25 |
2008-07-31 |
Actogenix N.V. |
Treatment of immune disease by mucosal delivery of antigens using genetically modified lactobacillus
|
|
WO2009006668A1
(en)
*
|
2007-02-05 |
2009-01-15 |
Children, Youth And Women's Health Service |
Modulators of antigen-dependent t cell proliferation
|
|
WO2009061208A1
(en)
|
2007-11-09 |
2009-05-14 |
Pronova Biopharma Norge As |
Lipid compounds for use in cosmetic products, as food supplement or as a medicament
|
|
JP5856843B2
(ja)
|
2008-05-27 |
2016-02-10 |
アンピオ ファーマシューティカルズ，インコーポレイテッド |
ジケトピペラジンを用いた医薬組成物
|
|
EP2147910A1
(en)
|
2008-07-15 |
2010-01-27 |
Pronova BioPharma Norge AS |
Novel lipid compounds
|
|
BRPI1015120B8
(pt)
|
2009-05-08 |
2022-02-15 |
Basf As |
Composto lipídico alfa-substituídos, derivados de ácidos graxos beta-oxo poli-insaturados, composição farmacêutica e lipídica e métodos para produzir composto lipídico e ácido 2-((5z,8z,11z,14z,17z)-icosa-5,8,11,14,17-pentaeniloxi)butanóico
|
|
GB0909643D0
(en)
*
|
2009-06-04 |
2009-07-22 |
Avexxin As |
Glomerulonephritis treatment
|
|
GB201014633D0
(en)
|
2010-09-02 |
2010-10-13 |
Avexxin As |
Rheumatoid arthritis treatment
|
|
EP2613786A4
(en)
|
2010-09-07 |
2013-10-23 |
Dmi Acquisition Corp |
TREATMENT OF DISEASES
|
|
ES2618604T3
(es)
|
2010-11-05 |
2017-06-21 |
Pronova Biopharma Norge As |
Métodos de tratamiento usando compuestos lipídicos
|
|
MY172699A
(en)
|
2011-10-10 |
2019-12-10 |
Ampio Pharmaceuticals Inc |
Implantable medical devices with increased immune tolerance, and methods for making and implanting
|
|
EA028343B1
(ru)
|
2011-10-10 |
2017-11-30 |
Ампио Фармасьютикалз, Инк. |
Лечение дегенеративного заболевания сустава
|
|
EP2771007B1
(en)
|
2011-10-28 |
2018-04-04 |
Ampio Pharmaceuticals, Inc. |
Treatment of rhinitis
|
|
GB201205394D0
(en)
|
2012-03-27 |
2012-05-09 |
Adlens Ltd |
Improvements in or relating to deformable non-round membrane assemblies
|
|
CN104219964B
(zh)
|
2012-03-30 |
2016-09-21 |
奇华顿股份有限公司 |
作为食品加香化合物的n-酰基脯氨酸衍生物
|
|
JP6452201B2
(ja)
|
2012-03-30 |
2019-01-16 |
ジボダン エス エー |
食品フレーバー付与化合物としてのｎ−アシル−アミノ酸誘導体、それらを含有する粉末組成物
|
|
CN104254253B
(zh)
|
2012-03-30 |
2017-12-29 |
奇华顿股份有限公司 |
作为食品加香化合物的n‑酰化甲硫氨酸衍生物
|
|
CN104219966B
(zh)
|
2012-03-30 |
2019-05-28 |
奇华顿股份有限公司 |
作为食品加香化合物的n-酰基-氨基酸衍生物
|
|
EP2830437B1
(en)
|
2012-03-30 |
2018-12-26 |
Givaudan SA |
N-acylated 1-aminocycloalkyl carboxylic acids as food flavouring compounds
|
|
WO2013149008A2
(en)
*
|
2012-03-30 |
2013-10-03 |
Givaudan, S.A. |
Improvements in or relating to organic compounds
|
|
CA2867316C
(en)
|
2012-03-30 |
2019-10-29 |
Givaudan S.A. |
N-acyl derivatives of gamma amino-butyric acid and beta alanine as food flavouring compounds
|
|
EP2830439B1
(en)
|
2012-03-30 |
2020-11-04 |
Givaudan SA |
N-acyl-gaba derivatives for the improvement of the flavour profile of edible compositions
|
|
GB201221329D0
(en)
*
|
2012-11-27 |
2013-01-09 |
Avexxin As |
Dermatitis treatment
|
|
MX377728B
(es)
|
2013-02-28 |
2025-03-11 |
Pronova Biopharma Norge As |
Composición que comprende un compuesto lípido, un triglicerido y un tensioactivo, y métodos de uso de la misma.
|
|
BR112015020469A2
(pt)
|
2013-03-15 |
2020-01-28 |
Ampio Pharmaceuticals Inc |
Usos de da-dkp, composição e método para fornecimento de células-tronco a umindivíduo
|
|
WO2015048991A1
(en)
|
2013-10-02 |
2015-04-09 |
Givaudan Sa |
Organic compounds having taste-modifying properties
|
|
WO2015050537A1
(en)
|
2013-10-02 |
2015-04-09 |
Givaudan S.A. |
Organic compounds
|
|
US10834950B2
(en)
|
2013-10-02 |
2020-11-17 |
Givaudan S.A. |
Organic compounds
|
|
WO2015050535A1
(en)
|
2013-10-02 |
2015-04-09 |
Givaudan S.A. |
Organic compounds
|
|
US10674755B2
(en)
|
2013-10-02 |
2020-06-09 |
Givaudan S.A. |
Organic Compounds
|
|
GB201317424D0
(en)
|
2013-10-02 |
2013-11-13 |
Givaudan Sa |
Improvements in or relating to organic compounds
|
|
EP3052472B1
(en)
|
2013-10-02 |
2019-02-27 |
Givaudan S.A. |
N-acylated 2-aminoisobutyric acid compounds and flavour compositions containing them
|
|
GB201409363D0
(en)
|
2014-05-27 |
2014-07-09 |
Avexxin As |
Skin cancer treatment
|
|
RU2736513C2
(ru)
|
2014-08-18 |
2020-11-17 |
Ампио Фармасьютикалз, Инк. |
Лечение патологических состояний суставов
|
|
ES2980790T3
(es)
|
2015-04-28 |
2024-10-03 |
Basf As |
Acidos grasos estructuralmente mejorados que contienen azufre para su uso en el tratamiento de la esteatohepatitis no alcohólica
|
|
EP3310375A4
(en)
|
2015-06-22 |
2019-02-20 |
Ampio Pharmaceuticals, Inc. |
USE OF LOW-MOLECULAR FRACTIONS OF HUMAN SERUMALBUMINE IN THE TREATMENT OF ILLNESSES
|
|
US11690825B2
(en)
|
2016-03-09 |
2023-07-04 |
Board Of Regents, The University Of Texas System |
20-HETE receptor (GPR75) antagonists and methods of use
|
|
GB201604316D0
(en)
|
2016-03-14 |
2016-04-27 |
Avexxin As |
Combination therapy
|
|
CN109789111B
(zh)
|
2016-09-21 |
2021-11-16 |
埃维克辛公司 |
药物组合物
|
|
IL308604B2
(en)
|
2017-12-06 |
2025-08-01 |
Basf As |
Fatty acid derivatives for treating non-alcoholic steatohepatitis
|